One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial?,??
Renato D.LopesMD, PhDabPedro Gabriel Melode Barros e SilvaMD, PhDbcdRemo H.M.FurtadoMD, PhDefAriane Vieira ScarlatelliMacedoMD, MScbEduardoRamacciottiMD, PhDbLucas PetriDaminiMSbcBrunaBronharaMSbAlexandre B.CavalcantiMD, PhDcgRegis G.RosaMD, PhDhiLuciano C.P.AzevedoMD, PhDhiViviane C.VeigaMD, PhDhjFl?via RMachadoMD, PhDhkLuiz EduardoRittMD, PhDlmPriscilla de AquinoMartinsMD, MScnJohn H.AlexanderMD, MHSaAlvaroAvezumMD, PhDoOtavioBerwangerMD, PhDeCoalition COVID-19 Brazil IV Investigators
doi : 10.1016/j.ahj.2021.04.005
Volume 238, August 2021, Pages 1-11
Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: The Fitbit heart study
Steven A.LubitzMD, MPHabAnthony Z.FaraneshPhDcSteven J.AtlasMD, MPHbdDavid D.McManusMD, ScMeDaniel E.SingerMDbdSherryPagotoPhDfAlexandrosPantelopoulosPhDcAndrea S.FoulkesPhDbg
doi : 10.1016/j.ahj.2021.04.003
Volume 238, August 2021, Pages 16-26
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial
ChristianZanchinMD, PhDa1Konstantinos C.KoskinasMDa1YasushiUekiMDaSylvainLosdatPhDbJonas D.H?nerMDaSarahB?rMDaTatsuhikoOtsukaMDaAndreaInderkumMScaMaria Radu JuulJensenMD, PhDcJacobLonborgMDcGregorFahrniMDdAnna S.OndracekeJoostDaemenMDfRobert-Janvan GeunsMDgJuan F.IglesiasMDhChristian M.MatterMDiDavidSpirkMDjPeterJuniMDkFrancoisMachMDhDikHegPhDbThomasEngstromcIreneLangeStephanWindeckerMDaLorenzR?berMD, PhDa
doi : 10.1016/j.ahj.2021.04.006
Volume 238, August 2021, Pages 33-44
Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial
XiulinShiab1JiangHecd1MingzhuLinabChangqinLiuabBingYanabHaiquSongabCaihongWangabFangsenXiaoabPeiyingHuangabLiyingWangabZhibinLieYinxiangHuangabMulinZhangabChung-ShiuanChencdKatherineObstcdWeihuaLifShuyuYangabGuanhuaYaogXuejunLiab1
doi : 10.1016/j.ahj.2021.04.009
Volume 238, August 2021, Pages 45-58
Financial burden, distress, and toxicity in cardiovascular disease
Samuel D.SlavinMDabRohanKheraMD, MSCScS. YousufZafarMDdefgKhurramNasirMD, MPHhiHaider J.WarraichMDabj
doi : 10.1016/j.ahj.2021.04.011
Volume 238, August 2021, Pages 75-84
Cangrelor vs. glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention
CharanYerasiMDBrian C.CaseMDChavaChezar-AzerradMDBrian J.ForrestalMDGiorgio A.MedrandaMDCoreySheaMSChengZhangPhDItsikBen-DorMDLowell F.SatlerMDNelson L.BernardoMDHayderHashimMDHector M.Garcia-GarciaMDPhDRonWaksmanMD
doi : 10.1016/j.ahj.2021.04.013
Volume 238, August 2021, Pages 59-65
Clinical features and outcomes in patients with cardiogenic shock complicating acute myocardial infarction: early vs recent experience with impella
HemindermeetSinghMDaRajendra H.MehtaMD, MSbWilliamO'NeillMDcNavin K.KapurMDdThomasLalondeMDeMagnusOhmanMDbIoanaGhiuMD, MSfYenChen-HsingMSfKareyDutcheshenMSN, FNP-CeTheodoreSchreiberMDeHowardRosmanMDeAmirKakiMDe
doi : 10.1016/j.ahj.2021.04.002
Volume 238, August 2021, Pages 66-74
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction
Jasmine MelissaMadsenMBa1Mia RavnJacobsenMDa1MuhammadSabbahMDaDivan GabrielTopalMD, PhDaRezaJabbariMD, PhDaCharlotteGlingeMD, PhDaLarsK?berMD, DMScaChristianTorp-PedersenMD, DMScbcFrantsPedersenMD, PhDaRikkeS?rensenMD, PhDaLeneHolmvangMD, DMScaThomasEngstr?mMD, DMScad2Jacob ThomsenL?nborgMD, DMSca2
doi : 10.1016/j.ahj.2021.04.012
Volume 238, August 2021, Pages 89-99
Individuals aged 1-64 years with documented congenital heart defects at healthcare encounters, five U.S. surveillance sites, 2011-2013
M.Jill GlidewellMSN, MPHaSherry L.FarrPhDaWendy M.BookMDbLorenzoBottoMDcJennifer S.LiMD, MHSdAida S.SoimPhD, MDeKarrie F.DowningMPHaTiffanyRiehle-ColarussoMD, MPHfAlfred AD'OttavioBSE, BEEdMarcia L.FeldkampPhDcAmber D.KhannaMS, MDgCheryl L.Raskind-HoodMS, MPHbKristin M.SommerhalterPhDeTessa LCrumeMS, PhDh
doi : 10.1016/j.ahj.2021.04.007
Volume 238, August 2021, Pages 100-108
Validity of different dose reduction criteria for apixaban
Nathaniel M.HawkinsMDaLeeErMScbRoopinder K.SandhuMD, MPHcdPadmaKaulPhDcdFinlay A.McAlisterMD, MScdeAdeeraLevinMDbfJason G.AndradeMDa
doi : 10.1016/j.ahj.2021.03.004
Volume 238, August 2021, Pages 12-15
Reduced-dose apixaban is recommended in patients fulfilling 2 of 3 criteria: age ?80 years, body weight ?60 kg, and serum creatinine ?1.5 mg/dL. However, patient weight is often not available in electronic health data. We examined the validity of alternative definitions based on age and renal function alone using an observational dataset of patients with atrial fibrillation and chronic kidney disease which included weight measurements.
Neighborhood education status drives racial disparities in clinical outcomes in PPCM
Kelly D.GetzPhD, MPHabJenniferLeweyMD, MPHcVickyTamMAdOlga CorazonIrizarryMDeLisa D.LevineMD, MSCEeRichardAplencMD, PhDabfZoltAranyMD, PhDc
doi : 10.1016/j.ahj.2021.03.015
Volume 238, August 2021, Pages 27-32
Electronic health record risk score provides earlier prognostication of clinical outcomes in patients admitted to the cardiac intensive care unit
YukikoKunitomoMDa#AlexanderThomasMDb#FouadChouairiBSbMaureen E.CanavanPhDcAjarKocharMD, MHSdRohanKheraMD, MSbeJason N.KatzMD, MHSfChristaMurphyRNgJacobJentzerMDhTariqAhmadMD, MPHbNihar R.DesaiMD, MPHbJosephBrennanMDbP. ElliottMillerMDbi
doi : 10.1016/j.ahj.2021.04.004
Volume 238, August 2021, Pages 85-88
